• Treatment recommended by NICE guidelines 2002 in the UK1 |
‐ GH deficiency, isolated or as part of multiple pituitary hormone deficiency |
‐ Turner syndrome |
‐ Prader Willi syndrome |
‐ Short stature associated with chronic renal failure |
• Licensed indications in Europe |
‐ GH deficiency, isolated or as part of multiple pituitary hormone deficiency |
‐ Turner syndrome |
‐ Prader Willi syndrome |
‐ Short stature associated with chronic renal failure |
‐ Short stature associated with low birth weight |
• Licensed in the USA, but not in Europe |
‐ Idiopathic short stature |
• Short stature conditions where there have been trials of treatment with GH but outcome is not clear (not licensed indications) |
‐ Noonan syndrome |
‐ Skeletal dysplasia |
‐ Rheumatoid arthritis |
‐ Down syndrome |
‐ Short stature associated with prolonged steroid use |
‐ Aarskog’s syndrome |